Ganglioglioma MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(43 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Ganglioglioma}}
{{Ganglioglioma}}
{{CMG}}
{{CMG}}{{AE}}{{MC}}


==Overview==
==Overview==


==MRI==
==MRI==
 
Brain MRI may be helpful in the diagnosis of ganglioglioma.
* Gangliogliomas share imaging features with other low-grade [[neoplasm]]s.
* In MRI imaging, ganglioglioma may appear as solid or cystic lesions.
* [[Calcification]] is a common finding.
* MRI T1-weighted images show a hypointense mass.
* Usually little or no associated mass effect or evidence of surrounding vasogenic edema.
* MRI T2-weighted and FLAIR images show a well-circumscribed hyperintense mass.
* Gangliogliomas have variable manifestations at nonenhanced CT and hypoattenuating mass is the most frequent manifestation.
* Ganglioglioma often does not enhance with intravenous gadolinium. However, some tumors have mild diffuse or patchy enhancement without ring appearance.
* Remodeling of the [[skull]] may be seen if the neoplasm is located within the peripheral brain.
* Conventionally they are sharply demarcated, but some are infiltrative and are indistinguishable from diffuse gliomas.
* MRI appearance of gangliogliomas is also variable and nonspecific.
* Anaplastic ganglioglioma is frequently infiltrative on MRI and is associated with a higher degree of gadolinium enhancement.
* In general, the lesions are hypointense to isointense relative to gray matter on T1 weighted images and hyperintense relative to gray matter on T2 weighted images.
* Overall, diagnosis might be suggested by clinical presentation and MRI characteristics, but the definitive diagnosis is only made by histopathological examination of the tumor. Review : <ref name="pmid26948368">{{cite journal| author=Soffietti R, Rudà R, Reardon D| title=Rare glial tumors. | journal=Handb Clin Neurol | year= 2016 | volume= 134 | issue=  | pages= 399-415 | pmid=26948368 | doi=10.1016/B978-0-12-802997-8.00024-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26948368  }} </ref> <ref name="">{{cite book | last = Hayat | first = M. A. | title = Tumors of the central nervous system | publisher = Springer | location = Dordrecht New York | year = 2012 | isbn = 978-94-007-5487-4 }}</ref> <ref name="RaizerNaidich2008">{{cite journal|last1=Raizer|first1=Jeffrey J.|last2=Naidich|first2=Michelle J.|title=Neuronal Tumors|year=2008|pages=435–448|doi=10.1016/B978-012370863-2.50045-2}}</ref>
* The frequency of enhancement following intravenous administration of iodinated contrast media is variable (16%–80%) of gangliogliomas.
 
<gallery>
Image:
 
Ganglioglioma-001.jpg
 
Image:
 
Ganglioglioma-002.jpg
 
Image:
 
Ganglioglioma-003.jpg
 
Image:
 
Ganglioglioma-004.jpg
 
</gallery>


==References==
==References==
Line 40: Line 20:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Neurology]]
[[Category:Neurology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 20:35, 2 August 2019

Ganglioglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Ganglioglioma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ganglioglioma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ganglioglioma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onGanglioglioma MRI

CDC on Ganglioglioma MRI

Ganglioglioma MRI in the news

on Ganglioglioma MRI

Directions to Hospitals Treating Ganglioglioma

Risk calculators and risk factors for Ganglioglioma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]

Overview

MRI

Brain MRI may be helpful in the diagnosis of ganglioglioma.

  • In MRI imaging, ganglioglioma may appear as solid or cystic lesions.
  • MRI T1-weighted images show a hypointense mass.
  • MRI T2-weighted and FLAIR images show a well-circumscribed hyperintense mass.
  • Ganglioglioma often does not enhance with intravenous gadolinium. However, some tumors have mild diffuse or patchy enhancement without ring appearance.
  • Conventionally they are sharply demarcated, but some are infiltrative and are indistinguishable from diffuse gliomas.
  • Anaplastic ganglioglioma is frequently infiltrative on MRI and is associated with a higher degree of gadolinium enhancement.
  • Overall, diagnosis might be suggested by clinical presentation and MRI characteristics, but the definitive diagnosis is only made by histopathological examination of the tumor. Review : [1] [2] [3]

References

  1. Soffietti R, Rudà R, Reardon D (2016). "Rare glial tumors". Handb Clin Neurol. 134: 399–415. doi:10.1016/B978-0-12-802997-8.00024-4. PMID 26948368.
  2. Hayat, M. A. (2012). Tumors of the central nervous system. Dordrecht New York: Springer. ISBN 978-94-007-5487-4.
  3. Raizer, Jeffrey J.; Naidich, Michelle J. (2008). "Neuronal Tumors": 435–448. doi:10.1016/B978-012370863-2.50045-2.


Template:WikiDoc Sources